About Tarus Therapeutics
Tarus Therapeutics is a company based in New York (United States) founded in 2019 by Donald R Dye and Peter Molloy was acquired by Portage Biotech in July 2022.. Tarus Therapeutics offers products and services including iNKT Platform, Adenosine Platform, and Other Programs.
- Headquarter New York, United States
- Founders Donald R Dye, Peter Molloy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Portage Biotech Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Portage Biotech
(Jul 06, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tarus Therapeutics
Tarus Therapeutics offers a comprehensive portfolio of products and services, including iNKT Platform, Adenosine Platform, and Other Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops therapies targeting cancer resistance pathways
Focuses on immuno-oncology drug development for cancer
Advances additional novel assets in oncology research
Funding Insights of Tarus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tarus Therapeutics
Tarus Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Portage Biotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics based on Cell Permeable Peptide Platform
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tarus Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tarus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tarus Therapeutics Comparisons
Competitors of Tarus Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tarus Therapeutics
Frequently Asked Questions about Tarus Therapeutics
When was Tarus Therapeutics founded?
Tarus Therapeutics was founded in 2019.
Where is Tarus Therapeutics located?
Tarus Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
What does Tarus Therapeutics do?
Tarus Therapeutics was founded in 2019 in New York, United States. Therapeutics for cancer treatment are developed by the company within the biotechnology sector. Lead candidates are focused on the immunosuppressive adenosine pathway in the tumor microenvironment. These candidates are aimed at addressing resistant cancers through operations centered on drug development. The companys activities are based in the United States.
What products or services does Tarus Therapeutics offer?
Tarus Therapeutics offers iNKT Platform, Adenosine Platform, and Other Programs.
Who are Tarus Therapeutics's investors?
Tarus Therapeutics has 1 investor. Key investors include Portage Biotech.